Physician profile
Melanie Macbeth
NPI 1700972726
$2,681.74
in general payments reported to CMS, 2019-2025
16 companies · $574 in 2025
The $574 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $32.90 · 2021: $171 · 2022: $404 · 2023: $815 · 2024: $460 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,830 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,830.36 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $591.41 | 2021-2025 | Tryptyr, Total30, Precision7 |
| Coopervision INC. | $552.43 | 2021-2025 | Myday Contact Lens, Clariti Contact Lens, Cvi Contact Lens |
| Bausch & Lomb Americas INC. | $473.27 | 2022-2025 | Miebo, Infuse, Xiidra |
| Visionary Optics LLC | $179.85 | 2023 | |
| Novartis Pharmaceuticals Corporation | $158.45 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $151.38 | 2019-2024 | Cequa |
| Allergan, INC. | $145.81 | 2019-2020 | |
| Abbvie INC. | $104.24 | 2022 | |
| Oyster Point Pharma, INC. | $91.73 | 2022-2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $91.66 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $61.66 | 2019-2025 | |
| Dompe US, INC. | $22.32 | 2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $18.12 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.97 | 2019 | |
| Shire North American Group INC | $11.69 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $9.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Macbeth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.